Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•

Product Recalls & Safety Alerts (3)

Category Archive →
Product Recalls & Safety Alerts

Medical Device Safety Notice: Ethylene Oxide Sterilization Residual Non-Conformance in Surgical Kits

29 Oct 2026

Regulatory safety notification addressing field recalls of sterile single-use surgical packs and catheters ( HS Code 9018.39 ) due to incomplete Ethylene Oxide (EO) aeration cycles and elevated residual 2-chloroethanol (ECH) concentrations. Biological & Chemical Thresholds: Sterilization lots must pass ISO 11135 validation using Bacillus atrophaeus biological indicators and conform strictly to ISO 10993-7 allowable daily exposure limits for EO and ECH. Quarantine Protocol: Institutional buyers must confirm valid degassing quarantine periods and review third-party gas chromatography residual test reports on import dossiers. Official Source & Verification Reference Issuing Authority: U.S. Food and Drug Administration (FDA) Safety Alerts • Reference: FDA-MED-EO-2026-10 Verify Official Source Document ↗

Read Full Notice & Official Source →
Product Recalls & Safety Alerts

Global Medical Product Alert: Mandatory DEG/EG Impurity Testing for Oral Liquid Pharmaceutical Excipients

27 Sept 2026

Urgent pharmacovigilance alert reinforcing zero-tolerance screening for Diethylene Glycol (DEG) and Ethylene Glycol (EG) contamination in liquid excipients, including Glycerin ( HS Code 2905.45 ), Propylene Glycol ( HS Code 2905.32 ), and Sorbitol solutions. Mandatory Release Testing: Every incoming drum of liquid excipient must undergo USP Gas Chromatography (GC-FID) limit testing confirming DEG and EG levels strictly ≤ 0.10% prior to compounding. Supply Chain Traceability: Wholesalers are advised to reject unsealed drums or secondary-repackaged excipients lacking original manufacturer Certificates of Analysis (COA) and intact tamper-evident seals. Official Source & Verification Reference Issuing Authority: World Health Organization (WHO) Substandard & Falsified Products Alert • Reference: WHO-MPA-DEG-2026 Verify Official Source Document ↗

Read Full Notice & Official Source →
Product Recalls & Safety Alerts

Regulatory Recall Advisory: Sub-Visible Particulate Matter & Glass Delamination in Parenteral Vials (USP <788>)

25 Aug 2026

Safety alert issued to hospital pharmacies and parenteral importers regarding voluntary batch recalls triggered by visible particulate matter and inner-surface glass delamination in sterile intravenous solutions ( HS Code 3004.90 ). Compendial Standard: Small-volume parenterals (&le;100 mL) must strictly meet USP &lt;788&gt; light obscuration limits (&le;6,000 particles &ge;10 &mu;m and &le;600 particles &ge;25 &mu;m per container). Importer Action: Distributors must verify Type I borosilicate glass hydrolytic resistance certifications (USP &lt;660&gt;) and inspect lot-release 100% automated optical inspection records prior to hospital distribution. Official Source &amp; Verification Reference Issuing Authority: U.S. Food and Drug Administration (FDA) &bull; Reference: FDA-ENF-RECALL-2026-08 Verify Official Source Document ↗

Read Full Notice & Official Source →